Company news
Dermata Therapeutics, Inc. news in 2026
Dermata Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
November 5, 2026
Dermata Advances Second Tome Skincare Product Toward Expected 2027 Launch with Initiation of Acne Clinical Trial
October 29, 2026
Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment
October 15, 2026
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
August 25, 2026
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 17, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026
August 11, 2026
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment
August 5, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
May 13, 2026
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
April 1, 2026
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
March 25, 2026
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
March 9, 2026
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
January 20, 2026